Zalsenertant tetraxetan lutetium Lu-177

DB17327InvestigationalSmall molecule

Zalsenertant tetraxetan lutetium Lu-177: Overview.

Mechanism: Pharmacologically active on Neurotensin receptor type 1
Curator reviewed
Also known as: 177Lu-3BP-227 · 177Lu-DOTA-3BP-227 · 177Lu-DOTA-IPN01087 · 177Lu-IPN01087 · Lutetium Lu 177 DOTA-3BP-227

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Zalsenertant tetraxetan lutetium Lu-177, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.